Product
Suvratoxumab
1 clinical trial
2 indications
Indication
Ventilator-associated pneumoniaIndication
Staphylococcus aureusClinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Efficacy and Safety of Suvratoxumab in Mechanically Ventilated Adults and Adolescents for the Prevention of Nosocomial PneumoniaStatus: Recruiting, Estimated PCD: 2023-10-01